These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8406232)

  • 1. [New animal models for drug discovery research: focus on cardiovascular diseases].
    Nakashima M; Umemura K; Takiguchi Y
    Nihon Yakurigaku Zasshi; 1993 Sep; 102(3):191-9. PubMed ID: 8406232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular disease models: A game changing paradigm in drug discovery and screening.
    Savoji H; Mohammadi MH; Rafatian N; Toroghi MK; Wang EY; Zhao Y; Korolj A; Ahadian S; Radisic M
    Biomaterials; 2019 Apr; 198():3-26. PubMed ID: 30343824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational In Vivo Models for Cardiovascular Diseases.
    Fliegner D; Gerdes C; Meding J; Stasch JP
    Handb Exp Pharmacol; 2016; 232():223-34. PubMed ID: 26552402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular pharmacotherapy: Innovation stuck in translation.
    Rongen GA; Wever KE
    Eur J Pharmacol; 2015 Jul; 759():200-4. PubMed ID: 25814253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Models of coronary artery occlusion and reperfusion for the discovery of novel antiischemic and antiinflammatory drugs for the heart.
    Wayman NS; McDonald MC; Chatterjee PK; Thiemermann C
    Methods Mol Biol; 2003; 225():199-208. PubMed ID: 12769489
    [No Abstract]   [Full Text] [Related]  

  • 6. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.
    Ruggeri BA; Camp F; Miknyoczki S
    Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo models for the evaluation of antithrombotics and thrombolytics.
    Mousa SA
    Methods Mol Biol; 2010; 663():29-107. PubMed ID: 20617414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs.
    Löscher W
    Neurochem Res; 2017 Jul; 42(7):1873-1888. PubMed ID: 28290134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference.
    Povsic TJ; Scott R; Mahaffey KW; Blaustein R; Edelberg JM; Lefkowitz MP; Solomon SD; Fox JC; Healy KE; Khakoo AY; Losordo DW; Malik FI; Monia BP; Montgomery RL; Riesmeyer J; Schwartz GG; Zelenkofske SL; Wu JC; Wasserman SM; Roe MT
    Cardiovasc Drugs Ther; 2017 Aug; 31(4):445-458. PubMed ID: 28735360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Airway disease: the use of large animal models for drug discovery.
    Van der Velden J; Snibson KJ
    Pulm Pharmacol Ther; 2011 Oct; 24(5):525-32. PubMed ID: 21356324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facilitating Drug Discovery in Human Disease Models Using Insects.
    Matsumoto Y
    Biol Pharm Bull; 2020; 43(2):216-220. PubMed ID: 32009109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zebrafish models of cardiovascular disease.
    Bournele D; Beis D
    Heart Fail Rev; 2016 Nov; 21(6):803-813. PubMed ID: 27503203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of preclinical animal models in pharmaceutical discovery and development: a need to bring in cerebro to the in vivo discussions.
    Everitt JI
    Toxicol Pathol; 2015 Jan; 43(1):70-7. PubMed ID: 25351920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considerations for the sensible use of rodent models of inflammatory disease in predicting efficacy of new biological therapeutics in the clinic.
    Arnett HA; Viney JL
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1084-92. PubMed ID: 17804112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting drug efficacy using integrative models for chronic respiratory diseases.
    Stevenson CS; Sridhar S; Phillips JE
    Inflamm Allergy Drug Targets; 2013 Apr; 12(2):124-31. PubMed ID: 23517645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From anatomy to the target: contributions of magnetic resonance imaging to preclinical pharmaceutical research.
    Beckmann N; Mueggler T; Allegrini PR; Laurent D; Rudin M
    Anat Rec; 2001 Apr; 265(2):85-100. PubMed ID: 11323771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational research challenges: finding the right animal models.
    Prabhakar S
    J Investig Med; 2012 Dec; 60(8):1141-6. PubMed ID: 23072902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of promising new cardiovascular drugs--pharmaceutical chemistry research and development.
    Am J Cardiol; 1974 Oct; 34(4):476-7. PubMed ID: 4413767
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative psychology and the grand challenge of drug discovery in psychiatry and neurodegeneration.
    Brunner D; Balcı F; Ludvig EA
    Behav Processes; 2012 Feb; 89(2):187-95. PubMed ID: 22155361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High human renin hypertension in transgenic rats.
    Bohlender J; Fukamizu A; Lippoldt A; Nomura T; Dietz R; Ménard J; Murakami K; Luft FC; Ganten D
    Hypertension; 1997 Jan; 29(1 Pt 2):428-34. PubMed ID: 9039138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.